Skip to search formSkip to main contentSkip to account menu

Perycit

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Niceritrol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
[The clinical effect of slow releasing nicotinate on hyperlipemic impotent patients].
  • T. HwangC. R. Yang
  • Zhonghua yi xue za zhi = Chinese medical journal…
  • 1993
  • Corpus ID: 28400523
Perycit (Pentaerythriol Tetranicotinate), a slow releasing drug, is one of the drugs used for treating hyperlipemia. Patients… 
1985
1985
The effects on lipids, blood viscosity and platelet aggregation of combined use of niceritrol (Perycit) and a low dose of acetylsalicylic acid.
1983
1983
高脂血症患者(Type II)におけるNiceritrol (perycit®)の血小板凝集能に及ぼす影響
1979
1979
Enzymatic hydrolysis of pentaerythritoltetranicotinate and meso-inositolhexanicotinate in blood and tissues.
The esters between nicotinic acid and pentaerythritol (niceritrol, Perycit) or meso-inositol (MIHN) were hydrolyzed by enzymes… 
1975
1975
Dose-response effect of single and combined clofibrate (Atromidin) and niceritrol (Perycit) treatment on serum lipids and lipoproteins in type II hyperlipoproteinaemia.
1974
1974
Clinical and metabolic effects of pentaerythritol tetranicotinate in combination with cholesolvin or clofibrate.
1974
1974
Clinical and metabolic effects of pentaerythritol tetranicotinate(Perycit)and a comparison with plain nicotinic acid.
1974
1974
Subacute administration of pentaerythritoltetranicotinate (perycit®) to man A study of plasma lipids and level of free nicotinic acid
1970
1970
Influence of nicotinic acid and pentaerythritoltetranicotinate (Perycit®, Bofors) on the cardiac output in man
SummaryThe effect of nicotinic acid and pentaerythritoltetranicotinate (Perycit®, Bofors) on cardiac output, FFA-level and… 
1969
1969
A study of some acute pharmacodynamic effects of pentaerythritoltetranicotinate (Perycit®) in man
SummaryThe nicotinic acid ester, pentaerythritol-tetranicotinate orally administered in a dose of 1 g produced a moderate but… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)